Profound Medical (PROF) Cash from Operations (2024 - 2026)

Profound Medical's Cash from Operations history runs 3 years deep, the most recent figure standing at 8583000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 3.62% year-over-year to 8583000.0 in Q1 2026; TTM through Mar 2026 was 38507000.0, a 41.53% decrease from a year earlier, with the FY2025 full-year figure at 38207000.0, down 62.91% from the prior year.
• Cash from Operations declined to 8583000.0 in Q1 2026 per PROF's latest filing, from 6566000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 4529000.0 in Q1 2024 and bottomed at 13744000.0 in Q2 2025.
• The 3-year median for Cash from Operations is 6826000.0 (2024), against an average of 7804777.78.
• Across the five-year window, Cash from Operations slumped 121.0% in 2025 and decreased 3.62% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 5879000.0 in 2024, then declined by 11.69% to 6566000.0 in 2025, then sank by 30.72% to 8583000.0 in 2026.
• Per Business Quant, the three latest PROF Cash from Operations figures stand at 8583000.0 (Q1 2026), 6566000.0 (Q4 2025), and 9614000.0 (Q3 2025).